Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




HPV-Positive Throat Cancer Responds Better to Treatment
Link ID 5773
Title HPV-Positive Throat Cancer Responds Better to Treatment
Url http://www.medscape.com/viewarticle/574532?src=rss
Description The study also revealed that patients with tumors that express high levels of EGFR had the poorest survival rates. WebMD Health News
Category Articles > Hematology-Oncology
Keywords
Date May 15, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Prostate Cancer Genetics
  Dr. Eric Topol discusses a flood of new data on common genetic variants that could predict prostate cancer.
Category:   Articles > Hematology-Oncology


2. T-Cell Recognition of Antigen Associated With Tumor Regression in Advanced Kidney Cancer After Stem
  After nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with metastatic renal cell carcinoma, donor T cells appear to target an antigen encoded by genes from human endogenous retrovirus. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Maintaining Quality of Life in Patients With Refractory Metastatic Breast Cancer: An Expert Intervie
  Sequential vs combination chemotherapy? Bevacizumab? Ixabepilone? Dr. Martine Piccart offers her perspectives on treatment for metastatic breast cancer, with particular focus on quality of life.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Androgen Receptor Promotes Invasiveness of Both Androgen-Dependent and Androgen-Refractory Prostate
  Androgen receptor not only promotes invasiveness of androgen-dependent and androgen-refractory prostate cancer, but it appears that a more invasive phenotype can develop as the disease progresses, through the activation of the androgen receptor Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Adjuvant Chemo Has Small Survival Benefit in Stage 2 Colorectal Cancer
  Results from the QUASAR trial show that adjuvant chemotherapy with fluorouracil improves survival in patients with stage 2 colorectal cancer, although the benefit is small. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS